Immunohistochemistry staining demonstrated that in TRAF2-shRNA tumor tissue, the expression of Ki67, which is a well-known biomarker to predict cell proliferative potentials, significantly decreased, implying NPC cell proliferative capabilities were impaired after TRAF2 was silenced. The gene discussed is TRAF2; the disease is neoplasm.